You are here

Novartis

Could This Biosimilar Drug Be Novartis' Next Blockbuster?

Motley Fool

Tue, 09/5/23 - 08:39 pm

Novartis updates on Sandoz finances ahead of spin-off

Pharmaphorum

Tue, 09/5/23 - 11:18 am

Novartis hits back at Entresto selection on Medicare list

Pharmaphorum

Wed, 08/30/23 - 10:01 am

Novartis: Leqvio Provides Low-density Lipoprotein Cholesterol Reduction Beyond 6 Years Of Treatment

RTT News

Mon, 08/28/23 - 12:05 pm

LDL cholesterol

clinical trials

Novartis Abandons Xoma-Partnered Antibody for Pancreatic Cancer

BioSpace

Mon, 08/28/23 - 11:39 am

pancreatic cancer

FDA Decisions 2023: Sandoz, Gilead Sciences and More

BioSpace

Fri, 08/25/23 - 11:31 am

Gilead Sciences

Revance Therapeutics

Delcath Systems

Galera Therapeutics

The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023

BioSpace

Wed, 08/23/23 - 11:11 am

Eiger Pharmaceuticals

Novartis to lay off another 100-plus employees at US HQ as global restructuring rolls on

Fierce Pharma

Tue, 08/22/23 - 11:38 pm

Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca

Yahoo/Zacks.com

Tue, 08/22/23 - 09:58 am

Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation

Biopharma Reporter

Mon, 08/21/23 - 06:50 pm

Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4

Fierce Pharma

Fri, 08/18/23 - 11:29 am

Sandoz plans to enter the Eylea biosimilar race

Clinical Trials Arena

Tue, 08/15/23 - 10:03 am

wet age-related macular degeneration

Spinal Muscular Atrophy: Four trials to watch over the next 12 months

Clinical Trials Arena

Fri, 08/11/23 - 11:39 am

clinical trials

spinal muscular atrophy

Novartis prepares for FDA submission for its chronic hives treatment

Clinical Trials Arena

Wed, 08/9/23 - 10:15 am

Novartis sickle cell drug’s approval formally revoked by EU regulators

BioPharma Dive

Sun, 08/6/23 - 09:27 pm

sickle cell disease

Biosimilar makers split strategies in bid to take on top-selling Humira

BioPharma Dive

Thu, 07/27/23 - 10:25 am

Boehringer Ingelheim

Scratching the surface of the urticaria pipeline

EP Vantage

Thu, 07/20/23 - 10:00 am

chronic urticaria

Celldex Therapeutics

Novartis raises drug sales forecast, plans new stock buybacks

BioPharma Dive

Tue, 07/18/23 - 10:23 pm

Novartis axes secretive obesity program after high-risk, high-reward bet fails

Fierce Biotech

Tue, 07/18/23 - 11:41 am

pancreatic cancer

Novartis buys a preclinical biotech and its RNA drug technology

BioPharma Dive

Mon, 07/17/23 - 07:07 pm

Pages